A detailed history of Grey Street Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Grey Street Capital, LLC holds 36,907 shares of LLY stock, worth $28.3 Million. This represents 3.89% of its overall portfolio holdings.

Number of Shares
36,907
Previous 30,154 22.4%
Holding current value
$28.3 Million
Previous $17.6 Billion 63.35%
% of portfolio
3.89%
Previous 8.37%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 09, 2024

BUY
$592.2 - $792.28 $4 Million - $5.35 Million
6,753 Added 22.4%
36,907 $28.7 Billion
Q4 2023

Jan 11, 2024

BUY
$525.19 - $619.13 $2.49 Million - $2.93 Million
4,734 Added 18.62%
30,154 $17.6 Billion
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $8.29 Million - $11.4 Million
19,070 Added 300.31%
25,420 $13.7 Billion
Q2 2023

Jul 13, 2023

BUY
$350.74 - $468.98 $2.23 Million - $2.98 Million
6,350 New
6,350 $2.98 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Grey Street Capital, LLC Portfolio

Follow Grey Street Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grey Street Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grey Street Capital, LLC with notifications on news.